CNBX Pharmaceuticals (CNBX) Financial Statements

CNBX Pharmaceuticals's market cap is currently $221.59K. The company's EPS TTM is $-0.009; its P/E ratio is -2.04; CNBX Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.